Effect of Time-restricted Eating on Cognitive Function and Other Biopsychosocial Factors in Menopausal Women Undertaking a 12-week Exercise Programme
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this quasi-experimental study is to test effect of time-restricted eating on cognitive function and other biopsychosocial factors in menopausal women undertaking a 12-week exercise programme. The main questions to answer are:
- blood samples collection (to measure level of brain-derived neurotrophic factor, glial cell derived neurotrophic factor, insulin, glucose, lipid profile),
- body composition analysis,
- Stroop test and N-back test,
- electroencephalography using Emotiv Epic X devices,
- One-repetition maximum test, Ruffier test,
- Questionnaire assessment (using Menopause Rating Scale and The Menopause-Specific Quality of Life Questionnaire). Researchers will compare two groups - exercise group and combination group which will do both time-restricted eating and exercise to see if there is a modulating effect of time-restricted eating in participants undertaking exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 7, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedNovember 18, 2023
November 1, 2023
1.5 years
November 7, 2023
November 13, 2023
Conditions
Outcome Measures
Primary Outcomes (14)
Brain-derived neurotrophic factor
Level of brain-derived neurotrophic factor in ng/ml
Before and after 12-week intervention
Glial cell derived neurotrophic factor
Level of glial cell derived neurotrophic factor in ng/ml
Before and after 12-week intervention
Insulin
Level of insulin in μIU/ml
Before and after 12-week intervention
Glucose
Level of glucose in mg/dl
Before and after 12-week intervention
LDL-cholesterol
Level of cholesterol LDL in mg/dl
Before and after 12-week intervention
Muscle mass
Bioelectrical impedance analysis for estimating body composition, in particular muscle mass in kg
Before and after 12-week intervention
Fat mass
Bioelectrical impedance analysis for estimating body composition, in particular fat mass in kg
Before and after 12-week intervention
Stroop test
Cognitive functions assessment with Stroop test in points. Higher scores means better outcome.
Before and after 12-week intervention
N-back test
Cognitive functions assessment with N-back test in points. Higher scores means better outcome.
Before and after 12-week intervention
Electroencephalography
Measurement of brain waves (alpha, beta, gamma, theta) to assess electrical activity of the brain using Emotiv Epoc X device
Before and after 12-week intervention
One-repetition maximum test
Strength assessment with one-repetition maximum test in kg
Before and after 12-week intervention
Ruffier test
Cardiorespiratory fitness assessment with Ruffier test in points. Minimum value is 0, maximum value is 10. Higher score means worse outcome.
Before and after 12-week intervention
Menopause Rating Scale
Menopausal symptoms assessment with Menopause Rating Scale in points. Minimum value is 0 and maximum value is 44. Higher score means worse outcome.
Before and after 12-week intervention
The Menopause-Specific Quality of Life Questionnaire
Menopausal symptoms assessment with The Menopause-Specific Quality of Life Questionnaire in points. Minimum value is 0 and maximum value is 174. Higher score means worse outcome.
Before and after 12-week intervention
Study Arms (2)
Exercise and Time-Restricted Eating
EXPERIMENTALExercise only
ACTIVE COMPARATORInterventions
Moderate intensity circuit mixed endurance and resistance exercise programme two times per week for 55 minutes for 12 weeks and a time-restricted eating following 16:8 protocol for 12 weeks.
Moderate intensity circuit mixed endurance and resistance exercise programme two times per week for 55 minutes for 12 weeks only.
Eligibility Criteria
You may qualify if:
- perimenopause, menopause or post-menopause
- lightly physically active or physically inactive
You may not qualify if:
- using hormone replacement therapy or hormonal contraception
- having significant contraindications to physical exercise or time-restricted eating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Poznan University of Physical Education
Poznan, Greater Poland Voivodeship, 61-871, Poland
Related Publications (2)
Jozwiak B, Kleka P, Laudanska-Krzeminska I. Effect of exercise alone and in combination with time-restricted eating on cognitive health in menopausal women. Front Public Health. 2025 Aug 13;13:1640512. doi: 10.3389/fpubh.2025.1640512. eCollection 2025.
PMID: 40880914DERIVEDJozwiak B, Domin R, Krzywicka M, Laudanska-Krzeminska I. Effect of exercise alone and in combination with time-restricted eating on cardiometabolic health in menopausal women. J Transl Med. 2024 Oct 21;22(1):957. doi: 10.1186/s12967-024-05738-y.
PMID: 39434160DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2023
First Posted
November 18, 2023
Study Start
August 1, 2021
Primary Completion
January 31, 2023
Study Completion
July 1, 2023
Last Updated
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share